ASSESSING APPROPRIATE DOSING OF NEW ORAL ANTICOAGULANTS: APIXABAN, DABIGATRAN AND RIVAROXABAN IN A TERTIARY HOSPITAL

ASSESSING APPROPRIATE DOSING OF NEW ORAL ANTICOAGULANTS: APIXABAN, DABIGATRAN AND RIVAROXABAN IN A TERTIARY HOSPITAL